Clinical Trial Update: Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring how atypical antipsychotics influence cardiac safety and monitoring indicators in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN